We are live on
!
Find out more
IHM
Iguana Healthcare Management Portfolio holdings
AUM
$152M
1-Year Est. Return
48.74%
This Fund
S&P 500
This Quarter
Est. Return
+16.53%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$6.64M
(+3.8%)
Cap. Flow
-$8.72M
Cap. Flow
% of AUM
-4.75%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
86
New
25
Increased
22
Reduced
18
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$3.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$3.21M |
| 3 |
Danaher
DHR
|
+$2.92M |
| 4 |
XLRN
Acceleron Pharma
XLRN
|
+$2.43M |
| 5 |
ESPR
Esperion Therapeutics
ESPR
|
+$2.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$6.61M |
| 2 |
AGN
Allergan plc
AGN
|
+$6.08M |
| 3 |
SPNC
Spectranetics Corp
SPNC
|
+$4.22M |
| 4 |
Sanofi
SNY
|
+$3.59M |
| 5 |
CELG
Celgene Corp
CELG
|
+$3.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.63% |
| 2 | Financials | 2.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Xencor
XNCR
$1.64B
| – | – |
-40,000
| Closed | -$844K |
|
|
RAD
77
DELISTED
Rite Aid Corporation
RAD
| – | – |
-7,500
| Closed | -$443K |
|
|
NUVA
78
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-35,000
| Closed | -$2.69M |
|
|
CLVS
79
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-40,000
| Closed | -$3.75M |
|
|
EPZM
80
DELISTED
Epizyme, Inc
EPZM
| – | – |
-75,000
| Closed | -$1.13M |
|
|
ALXN
81
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-25,000
| Closed | -$3.04M |
|
|
GWPH
82
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – |
-15,000
| Closed | -$1.5M |
|
|
IMMU
83
CALL
DELISTED
Immunomedics Inc
IMMU
| – | – |
-150,000
| Closed | -$1.32M |
|
|
AGN
84
DELISTED
Allergan plc
AGN
| – | – |
-25,000
| Closed | -$6.08M |
|
|
SPNC
85
DELISTED
Spectranetics Corp
SPNC
| – | – |
-110,000
| Closed | -$4.22M |
|
|
SHPG
86
DELISTED
Shire pic
SHPG
| – | – |
-40,000
| Closed | -$6.61M |
|
Similar funds
HWP
PAM
USG2
LCM
FPF
FIAS
CII
OPWM
Iguana Healthcare Management's Q3 2017 Portfolio in Review
As of Q3 2017, Iguana Healthcare Management held 86 positions worth $184M, up 3.8% from $177M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Iguana Healthcare Management withdrew a net $8.72M in Q3 2017, closing 18 positions and reducing 18 holdings. Its most notable exit was Shire pic, an estimated $6.61M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 70% a quarter earlier, followed by Financials.
Against the trend, Iguana Healthcare Management opened a new position in Bristol-Myers Squibb worth $3.51M.
- Iguana Healthcare Management's largest Q3 2017 buy was Bristol-Myers Squibb: 55,000 shares worth $3.51M.
- Iguana Healthcare Management added most to Biogen in Q3 2017, an estimated $3.7M increase.
- Iguana Healthcare Management's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $3.06M.
- Iguana Healthcare Management fully exited Shire pic in Q3 2017, selling an estimated $6.61M.
- Iguana Healthcare Management's ten largest holdings make up 36% of its $184M portfolio in Q3 2017.
- Iguana Healthcare Management opened 25 new positions and closed 18 in Q3 2017.
- Iguana Healthcare Management's portfolio value rose 3.8% quarter-over-quarter to $184M.
Based on Iguana Healthcare Management's 13F filing for Q3 2017, filed 14 Nov 2017.